Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D001590:Benztropine / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy*; D009461:Neurologic Manifestations; D010276:Parasympatholytics / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use; D014326:Tropanes / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D014326:Tropanes; D001590:Benztropine